Skip to content

Evaluation of cholesterol reduction effect by ingesting concentrated red malt

Evaluation of cholesterol reduction effect by ingesting concentrated red malt - Evaluation of cholesterol reduction effect by ingesting supplement.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029727
Enrollment
30
Registered
2017-10-27
Start date
2017-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Test 2 capsules once once a day after dinner with water Placebo 2 capsules once once a day after dinner with water

Sponsors

Shiba Palace Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese males and females aged 30 to 59 years old at the time of acquiring consent on the first observation day (equal males and females) 2) Persons who have increased serum cholesterol

Exclusion criteria

Exclusion criteria: 1) Persons who are taking medications (lipid-lowering drugs, etc.) that are likely to affect the test results 2) Persons routinely taking health foods (supplements with cholesterol-reducing effect, etc.) that are likely to affect the test results 3) Alcohol addiction 4) Persons who are likely to have allergic symptoms depending on the test article component 5) Participating in other clinical trials 6) Persons who have a history of serious liver disorder, kidney disorder, heart disease 7) Persons who have a history of hepatitis or who are currently suffering from hepatitis 8) Persons with serious anemia 9) Persons who are judged inappropriate to participate the study by the supervising doctor (When recognizing the fact that it is determined to be ineligible during the course of the test, it is excluded from the analysis subject. Note that inspection items that are not screening criteria are not an exclusion criterion from screening.)

Design outcomes

Primary

MeasureTime frame
Blood test(LDL cholesterol)

Secondary

MeasureTime frame
Measurement of blood pressure and pulse Blood test Diet survey Doctor's findings and evaluations Dietary advice Physical measurement Health diary

Countries

Japan

Contacts

Public ContactKo Masuda

SOUKEN Co., Ltd Management Division

k_masuda@mail.souken-r.com03-5408-1555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026